The Causal Role of Ketone Bodies in Obesity-Associated Disease Prevention - Combining Genetic Epidemiology With a Randomised Trial to Infer Causality
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 69
- 试验地点
- 1
- 主要终点
- Transcriptome of adipose tissue
研究概览
简要总结
Excess weight increases the risk of several diseases including cardiovascular disease, type 2 diabetes, kidney disease and various cancers. There is a need for preventative strategies for obesity-associated disease, especially for people in the overweight and moderately obese ranges where pharmacological intervention may not be suitable.
Low-carbohydrate (ketogenic) diets are popular for weight control. Ketogenic diets increase circulating ketones, which can have favourable effects on cardiometabolic health markers. However, the ketogenic diet has a nutrient composition associated with harms (high-saturated fat/red meat, and low-fibre). The net effects of ketogenic diets on long-term health are unclear. Ketone supplements can increase circulating ketones and could provide benefits of ketosis without needing to adhere to a potentially harmful diet.
Establishing causality between complex exposures (e.g., diet) and long-term outcomes (e.g., disease), is challenging. The MRC & NIHR Review of Nutrition and Human Health Research (2017) highlighted an "overreliance (as opposed to reasonable reliance) on observational studies" as a key barrier to progression in the field of nutrition and health. Randomised controlled trials (RCTs) facilitate causal inference, but for long-term outcomes are expensive, time-consuming, and often suffer from waning adherence. Mendelian randomization (MR) can estimate causal effects subject to key assumptions. A challenge to these assumptions includes complex behavioural exposures (e.g., diet), which could be intercorrelated with causal factors.
Our proposal will address these limitations with a novel combination of study designs to establish causal effects of ketosis (via diet and supplementation) on obesity-associated disease risk in humans.
The investigators will combine a tightly controlled, short-term RCT, with MR to link short-term responses to long-term endpoints. The investigators will examine the circulating (blood) and tissue-specific (adipose) transcriptomic and proteomic responses in the fasted and postprandial state in response to our dietary interventions and translate these to MR by identifying single-nucleotide polymorphisms from genome wide association studies. This approach overcomes limitations of RCTs and MR, as adherence to diets will be confirmed with controlled feeding, and intermediate molecular traits as exposure for MR are less likely to be intercorrelated with causal traits.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Basic Science
- 盲法
- None (Participant, Investigator, Outcomes Assessor)
盲法说明
Outcome assessors will be masked to the group allocation when analysis is outsourced from the University.
入排标准
- 年龄范围
- 18 Years 至 65 Years(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Body mass index: 25-45 kg/m2
- •Waist circumference >93.9 (males) or >79.9 (females)
排除标准
- •Glucose or lipid lowering medication
- •Diagnosis of cardiovascular disease, renal failure, liver disease or type 2 diabetes
- •Contraindications to a ketogenic diet (e.g., pancreatitis, liver failure, disorders of fat metabolism, primary carnitine deficiency, carnitine palmitoyltransferase deficiency, carnitine translocase deficiency, porphyrias, or pyruvate kinase deficiency)
- •Unable to understand English language
研究组 & 干预措施
CONTROL
KETONE ESTER
干预措施: Ketone Monoester (KE) (Dietary Supplement)
KETOGENIC DIET
干预措施: Ketogenic diet (Behavioral)
结局指标
主要结局
Transcriptome of adipose tissue
时间窗: From baseline to week 4
Transcriptome of subcutaneous abdominal adipose tissue at week 4 adjusting for baseline values
Plasma proteome
时间窗: From baseline to week 4
Plasma proteome at week 4 adjusted for baseline values
Transcriptome of peripheral blood mononuclear cells
时间窗: From baseline to week 4
Transcriptome of peripheral blood mononuclear cells at week 4 adjusting for baseline values
次要结局
- Apolipoprotein B concentrations(From baseline to week 4)
- Urinary albumin concentrations(From baseline to week 4)
- Fasting glucose concentrations(From baseline to week 4)
研究者
Javier Gonzalez
Professor of Nutrition and Metabolism
University of Bath
